查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1654447

子宮內膜異位症治療市場規模、佔有率、趨勢分析報告，按治療類型、藥物類別、給藥途徑、分銷管道、地區、細分預測，2025-2030 年

Endometriosis Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

子宮內膜異位症治療市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，全球子宮內膜異位症治療市場規模預計到2030年將達到35.2億美元，2025-2030年期間的複合年成長率為12.25%。

該市場的成長得益於強大的後期產品平臺、全球病例的急劇增加以及國內外政府和主要企業為提高人們對該疾病的認知而採取的多項舉措。

預計，太空領域新治療方案的研究和開發日益增多，將為未來幾年的市場成長提供豐厚的機會。 Myovant/輝瑞的 Relugolix 複方片劑、ObsEva 的 Yselty（Linzagolix）以及 Ferring Pharmaceuticals/諾華的 Quinagolide 的推出是該領域值得關注的藥物，預計將推動市場成長。

子宮內膜異位症治療的需求不斷成長，是由於疾病負擔不斷加重以及診斷延遲導致病情惡化。根據世界衛生組織統計，截至 2021 年 3 月，約有 10% 的女性育齡人口受到該疾病的影響。根據論文《子宮內膜異位症診斷延遲對醫療資源利用和成本的影響》，與症狀出現後更早診斷的患者相比，在出現首個症狀後超過三年才進行診斷的患者，症狀負擔會加重，醫療費用也會增加 50%。

世界衛生組織、各國政府和私人組織正在策略性地努力提高人們對子宮內膜異位症及其治療的認知，支持市場的成長。例如，2022 年 3 月，美國子宮內膜異位症基金會舉辦了為期四週的虛擬項目，邀請患者和醫生參與，幫助子宮內膜異位症患者建立聯繫，共用他們與疾病抗爭的經歷。此外，2022年3月，英國子宮內膜異位症協會也推出了子宮內膜異位症行動月八點行動計畫。

此外，主要企業正在採取併購、合作、財務投資和地理擴張等策略性舉措，以推動子宮內膜異位症治療市場的發展。例如，2021年11月，Organon and Co.宣布收購Forendo Pharma，以支持開發新藥的子宮內膜異位症藥物，例如Forendo的2期臨床候選藥物OR-6219。

子宮內膜異位症治療市場報告重點

  • 根據治療類型，由醫生給藥的高劑量荷爾蒙療法將在 2024 年佔據最大的市場佔有率。
  • 2024 年，促性腺激素分泌釋放激素 (GnRH) 藥物類別佔據主導地位，這歸因於 GnRH促效劑和 GnRH 拮抗劑的高效性以及這些產品在市場上的供應量不斷增加。
  • 從2024年按給藥途徑分類的佔有率來看，口服藥物將佔據市場的主導地位，佔48.46%。對於該領域中的大多數產品來說，口服是最常見、最方便的給藥途徑。
  • 按分銷管道分類，零售藥局將在 2024 年佔據市場主導地位。此外，醫院藥房預計也將實現適度成長。
  • 由於疾病盛行率不斷上升以及人們和醫療專業人員對治療症狀的認知不斷提高，北美在 2024 年佔據了全球市場的主導地位。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章市場變數和趨勢

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場趨勢與展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 波特五力分析
    • PESTEL 分析
  • 管道分析（第 3 階段）

4. 子宮內膜異位症治療市場區隔分析（依治療類型），2018 年至 2030 年

  • 子宮內膜異位症治療市場：治療類型變化分析
  • 按治療類型
    • 止痛藥
    • 荷爾蒙療法

5. 子宮內膜異位症治療市場區隔分析（依藥物類別），2018 年至 2030 年

  • 子宮內膜異位症治療市場：藥物類別變化分析
  • 按藥品類別
    • NSAID
    • 口服避孕藥
    • 促性腺激素分泌釋放激素
    • 其他

6. 子宮內膜異位症治療市場依給藥途徑細分分析，2018 年至 2030 年

  • 子宮內膜異位症治療市場：給藥途徑變化分析
  • 依給藥途徑
    • 口服
    • 注射
    • 其他

7. 子宮內膜異位症治療市場區隔分析（依通路），2018 年至 2030 年

  • 子宮內膜異位症治療市場：通路變化分析
  • 按分銷管道
    • 醫院藥房
    • 零售藥局
    • 其他

第 8 章子宮內膜異位症治療市場：按類型、藥物類別、給藥途徑、通路和地區進行的估計和趨勢分析

  • 子宮內膜異位症治療市場：區域展望
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 參與企業
  • Participants'Overviews
  • 企業市場分析
  • 公司簡介
    • Bayer AG
    • Pfizer, Inc.
    • AbbVie, Inc
    • AstraZeneca
    • ObsEva SA
    • Teva Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • ELI LILLY AND COMPANY
    • Astellas Pharma, Inc.
  • 戰略地圖
    • 新產品發布
    • 獲得
    • 合作
    • 夥伴關係
    • 其他（臨床測試、宣傳活動、法律、定價）

第 10 章 結論

Product Code: GVR-4-68040-005-5

Endometriosis Treatment Market Growth & Trends:

The global endometriosis treatment market size is expected to reach USD 3.52 billion by 2030, registering a CAGR of 12.25% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market growth is attributed to the presence of a late-stage robust product pipeline, the global upsurge in cases, and several initiatives undertaken by the government and key players at national and international levels to raise disease awareness.

The growing research and development for new treatment options in space is expected to offer a lucrative opportunity for market growth in the coming years. The launch of Myovant / Pfizer's Relugolix combination tablet, ObsEva's Yselty (linzagolix), and Ferring Pharmaceuticals / Novartis' Quinagolide are among prominent drug launches in this space that are anticipated to fuel the market growth.

Rising demand for endometriosis treatment is attributed to increasing disease burden and delay in diagnosis, worsening the disease condition. In March 2021, as per WHO, approximately 10% of female reproductive population is affected by the disease worldwide. According to the article, "Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs", a delay of three or more years in diagnosis from developing first symptom leads to increase in symptom burden and increase in healthcare cost by 50% compared with patients who were diagnosed earlier after symptom onset.

WHO, national governments, and private organizations are strategically involved in spreading awareness and educating people about endometriosis and its treatment, thereby supporting market growth. For instance, in March 2022, the Endometriosis Foundation of America hosted four weekends of the virtual program featuring patients and physicians, helping to connect endometriosis warriors and share their experiences with the disease. Moreover, in March 2022, Endometriosis U.K. also launched an eight-point action plan during the 'Endometriosis Action Month'.

Furthermore, key players are undertaking strategic initiatives such as mergers and acquisitions, collaborations, financial investments, and geographical expansion fueling the endometriosis treatment market. For instance, in November 2021, Organon and Co. announced to acquire Forendo Pharma, which will support Forendo's development of novel drugs in endometriosis like OR-6219, a phase 2 clinical candidate.

Endometriosis Treatment Market Report Highlights:

  • By treatment type, the hormone therapy segment accounted for the largest share of the market in 2024 due to the high prescription rate of these drugs by physicians
  • Gonadotropin-releasing hormone (GnRH) segment dominated the drug class segment in 2024 due to the high efficacy of GnRH agonists and GnRH antagonists and the increased availability of these products in the market
  • In 2024, oral segment dominated the market with a 48.46% share by route of administration. It is the most common & convenient route of delivery for the majority of products in this space
  • In 2024, retail pharmacy segment dominated the market by distribution channel. Moreover, hospital pharmacy is expected to demonstrate moderate growth
  • North America dominated the global market in 2024 owing to increased disease incidence and high awareness among people and healthcare professionals about the condition therapies

Table of Content

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Regional Scope
  • 1.2 Market Definitions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Objectives
    • 1.3.1 Objective - 1
    • 1.3.2 Objective - 2
    • 1.3.3 Objective - 3
  • 1.4 Research Methodology
  • 1.5 Information Procurement
    • 1.5.1 Purchased Database
    • 1.5.2 Gvr's Internal Database
    • 1.5.3 Secondary Sources
    • 1.5.4 Primary Research
    • 1.5.5 Details Of Primary Research
  • 1.6 Information or Data Analysis
    • 1.6.1 Data Analysis Models
  • 1.7 Market Formulation & Validation
  • 1.8 Model Details
    • 1.8.1 Commodity Flow Analysis
      • 1.8.1.1 Approach 1: Commodity Flow Approach
      • 1.8.1.2 Approach 2: Country wise market estimation using bottom-up approach
  • 1.9 List of Secondary Sources
  • 1.10 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Treatment Type and Drug Class Segment Snapshot
  • 2.3 Route of Administration and Distribution Channel Segment Snapshots
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Market Variables and Trends

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Market Trends & Outlook
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Rising disease burden
      • 3.3.1.2 Growing awareness toward the disease
      • 3.3.1.3 Increasing funding for research and development
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Availability of over the counter and generic drugs
  • 3.4 Business Environment Analysis
    • 3.4.1 PORTER'S Five Forces Analysis
    • 3.4.2 PESTEL Analysis
  • 3.5 Pipeline Analysis (Phase 3)

Chapter 4 Endometriosis Treatment Market- Segment Analysis, by Treatment Type, 2018 - 2030 (USD Million)

  • 4.1 Endometriosis Treatment Market: Treatment Type Movement Analysis
  • 4.2 Endometriosis Treatment Market Estimates & Forecast, By Treatment Type (USD Million)
    • 4.2.1 Pain Medication
    • 4.2.2 Hormone Therapy

Chapter 5 Endometriosis Treatment Market- Segment Analysis, by Drug Class, 2018 - 2030 (USD Million)

  • 5.1 Endometriosis Treatment Market: Drug Class Movement Analysis
  • 5.2 Endometriosis Treatment Market Estimates & Forecast, By Drug Class (USD Million)
    • 5.2.1 Nsaids
    • 5.2.2 Oral Contraceptives
    • 5.2.3 Gonadotropin-Releasing Hormone
    • 5.2.4 Others

Chapter 6 Endometriosis Treatment Market- Segment Analysis, by Route of Administration, 2018 - 2030 (USD Million)

  • 6.1 Endometriosis Treatment Market: Route of Administration Movement Analysis
  • 6.2 Endometriosis Treatment Market Estimates & Forecast, By Route of Administration (USD Million)
    • 6.2.1 Oral
    • 6.2.2 Injectable
    • 6.2.3 Others

Chapter 7 Endometriosis Treatment Market- Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)

  • 7.1 Endometriosis Treatment Market: Distribution Channel Movement Analysis
  • 7.2 Endometriosis Treatment Market Estimates & Forecast, By Distribution Channel (USD Million)
    • 7.2.1 Hospital Pharmacies
    • 7.2.2 Retail Pharmacies
    • 7.2.3 Others

Chapter 8 Endometriosis Treatment Market: Regional Estimates and Trend Analysis by Type, Drug Class, Route of Administration, and Distribution Channel

  • 8.1 Endometriosis Treatment Market: Regional Outlook
  • 8.2 North America
    • 8.2.1 North America Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 Key Country Dynamics
      • 8.2.2.2 U.S. Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.2.2.3 Competitive/Market Scenario
      • 8.2.2.4 Regulatory Framework
      • 8.2.2.5 Reimbursement Scenario
    • 8.2.3 Canada
      • 8.2.3.1 Key Country Dynamics
      • 8.2.3.2 Canada Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.2.3.3 Competitive/Market Scenario
      • 8.2.3.4 Regulatory Framework
      • 8.2.3.5 Reimbursement Scenario
    • 8.2.4 Mexico
      • 8.2.4.1 Key Country Dynamics
      • 8.2.4.2 Mexico Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.2.4.3 Competitive/Market Scenario
      • 8.2.4.4 Regulatory Framework
      • 8.2.4.5 Reimbursement Scenario
  • 8.3 Europe
    • 8.3.1 Europe Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2 UK
      • 8.3.2.1 Key Country Dynamics
      • 8.3.2.2 UK Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.3 Competitive/Market Scenario
      • 8.3.2.4 Regulatory Framework
      • 8.3.2.5 Reimbursement Scenario
    • 8.3.3 Germany
      • 8.3.3.1 Key Country Dynamics
      • 8.3.3.2 Germany Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.3.3 Competitive/Market Scenario
      • 8.3.3.4 Regulatory Framework
      • 8.3.3.5 Reimbursement Scenario
    • 8.3.4 France
      • 8.3.4.1 Key Country Dynamics
      • 8.3.4.2 France Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.4.3 Competitive/Market Scenario
      • 8.3.4.4 Regulatory Framework
      • 8.3.4.5 Reimbursement Scenario
    • 8.3.5 Italy
      • 8.3.5.1 Key Country Dynamics
      • 8.3.5.2 Italy Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.5.3 Competitive/Market Scenario
      • 8.3.5.4 Regulatory Framework
      • 8.3.5.5 Reimbursement Scenario
    • 8.3.6 Spain
      • 8.3.6.1 Key Country Dynamics
      • 8.3.6.2 Spain Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.6.3 Competitive/Market Scenario
      • 8.3.6.4 Regulatory Framework
      • 8.3.6.5 Reimbursement Scenario
    • 8.3.7 Denmark
      • 8.3.7.1 Key Country Dynamics
      • 8.3.7.2 Denmark Influenza Vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.3.7.3 Competitive/Market Scenario
      • 8.3.7.4 Regulatory Framework
      • 8.3.7.5 Reimbursement Scenario
    • 8.3.8 Sweden
      • 8.3.8.1 Key Country Dynamics
      • 8.3.8.2 Sweden Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.8.3 Competitive/Market Scenario
      • 8.3.8.4 Regulatory Framework
      • 8.3.8.5 Reimbursement Scenario
    • 8.3.9 Norway
      • 8.3.9.1 Key Country Dynamics
      • 8.3.9.2 Norway Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.9.3 Competitive/Market Scenario
      • 8.3.9.4 Regulatory Framework
      • 8.3.9.5 Reimbursement Scenario
    • 8.3.10 Rest Of Europe Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Key Country Dynamics
      • 8.4.2.2 Japan Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.2.3 Competitive/Market Scenario
      • 8.4.2.4 Regulatory Framework
      • 8.4.2.5 Reimbursement Scenario
    • 8.4.3 China
      • 8.4.3.1 Key Country Dynamics
      • 8.4.3.2 China Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.3.3 Competitive/Market Scenario
      • 8.4.3.4 Regulatory Framework
      • 8.4.3.5 Reimbursement Scenario
    • 8.4.4 India
      • 8.4.4.1 Key Country Dynamics
      • 8.4.4.2 India Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.4.3 Competitive/Market Scenario
      • 8.4.4.4 Regulatory Framework
      • 8.4.4.5 Reimbursement Scenario
    • 8.4.5 Australia
      • 8.4.5.1 Key Country Dynamics
      • 8.4.5.2 Australia Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.5.3 Competitive/Market Scenario
      • 8.4.5.4 Regulatory Framework
      • 8.4.5.5 Reimbursement Scenario
    • 8.4.6 Thailand
      • 8.4.6.1 Key Country Dynamics
      • 8.4.6.2 Thailand Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.6.3 Competitive/Market Scenario
      • 8.4.6.4 Regulatory Framework
      • 8.4.6.5 Reimbursement Scenario
    • 8.4.7 South Korea
      • 8.4.7.1 Key Country Dynamics
      • 8.4.7.2 South Korea Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.7.3 Competitive/Market Scenario
      • 8.4.7.4 Regulatory Framework
      • 8.4.7.5 Reimbursement Scenario
    • 8.4.8 Rest Of Asia Pacific Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Key Country Dynamics
      • 8.5.2.2 Brazil Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.5.2.3 Competitive/Market Scenario
      • 8.5.2.4 Regulatory Framework
      • 8.5.2.5 Reimbursement Scenario
    • 8.5.3 Argentina
      • 8.5.3.1 Key Country Dynamics
      • 8.5.3.2 Argentina Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.5.3.3 Competitive/Market Scenario
      • 8.5.3.4 Regulatory Framework
      • 8.5.3.5 Reimbursement Scenario
    • 8.5.4 Rest Of Latin America Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6 Middle East & Africa (MEA)
    • 8.6.1 Mea Endometriosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 Key Country Dynamics
      • 8.6.2.2 South Africa Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.6.2.3 Competitive/Market Scenario
      • 8.6.2.4 Regulatory Framework
      • 8.6.2.5 Reimbursement Scenario
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Key Country Dynamics
      • 8.6.3.2 Saudi Arabia Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.6.3.3 Competitive/Market Scenario
      • 8.6.3.4 Regulatory Framework
      • 8.6.3.5 Reimbursement Scenario
    • 8.6.4 UAE
      • 8.6.4.1 Key Country Dynamics
      • 8.6.4.2 UAE Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.6.4.3 Competitive/Market Scenario
      • 8.6.4.4 Regulatory Framework
      • 8.6.4.5 Reimbursement Scenario
    • 8.6.5 Kuwait
      • 8.6.5.1 Key Country Dynamics
      • 8.6.5.2 Kuwait Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.6.5.3 Competitive/Market Scenario
      • 8.6.5.4 Regulatory Framework
      • 8.6.5.5 Reimbursement Scenario
    • 8.6.6. Rest of MEA Endometriosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Participant Categorization
  • 9.2 Participants' Overviews
  • 9.3 Financial Performance
  • 9.4 Product Benchmarking
  • 9.5 Company Market Position Analysis
  • 9.6 Company Profiles
    • 9.6.1 Bayer AG
      • 9.6.1.1 Company Overview
      • 9.6.1.2 Financial Performance
      • 9.6.1.3 Product Benchmarking
      • 9.6.1.4 Strategic Initiatives
    • 9.6.2 Pfizer, Inc.
      • 9.6.2.1 Company Overview
      • 9.6.2.2 Financial Performance
      • 9.6.2.3 Product Benchmarking
      • 9.6.2.4 Strategic Initiatives
    • 9.6.3 AbbVie, Inc
      • 9.6.3.1 Company Overview
      • 9.6.3.2 Financial Performance
      • 9.6.3.3 Product Benchmarking
      • 9.6.3.4 Strategic Initiatives
    • 9.6.4 AstraZeneca
      • 9.6.4.1 Company Overview
      • 9.6.4.2 Financial Performance
      • 9.6.4.3 Product Benchmarking
      • 9.6.4.4 Strategic Initiatives
    • 9.6.5 ObsEva SA
      • 9.6.5.1 Company Overview
      • 9.6.5.2 Financial Performance
      • 9.6.5.3 Product Benchmarking
      • 9.6.5.4 Strategic Initiatives
    • 9.6.6 Teva Pharmaceutical Industries Ltd.
      • 9.6.6.1 Company Overview
      • 9.6.6.2 Financial Performance
      • 9.6.6.3 Product Benchmarking
      • 9.6.6.4 Strategic Initiatives
    • 9.6.7 Teva Pharmaceutical Industries Ltd.
      • 9.6.7.1 Company Overview
      • 9.6.7.2 Financial performance
      • 9.6.7.3 Product Benchmarking
      • 9.6.7.4 Strategic Initiatives
    • 9.6.8 ELI LILLY AND COMPANY
      • 9.6.8.1 Company Overview
      • 9.6.8.2 Financial performance
      • 9.6.8.3 Product Benchmarking
      • 9.6.8.4 Strategic Initiatives
    • 9.6.9 Astellas Pharma, Inc.
      • 9.6.9.1 Company Overview
      • 9.6.9.2 Financial performance
      • 9.6.9.3 Product Benchmarking
      • 9.6.9.4 Strategic Initiatives
  • 9.7 Strategy Mapping
    • 9.7.1 New Product Launches
    • 9.7.2 Acquisition
    • 9.7.3 Collaborations
    • 9.7.4 Partnerships
    • 9.7.5 Others (Clinical Trials, Campaign, Legal, And Pricing)

Chapter 10 Conclusion

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 List of Parameters
  • Table 4 List of Distributors
  • Table 5 Global Endometriosis Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 6 Global Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 7 Global Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 8 Global Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9 Global Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 10 North America Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 11 North America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 12 North America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 13 North America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 14 North America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15 U.S. Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 17 U.S. Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 18 U.S. Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 19 Canada Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 20 Canada Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 21 Canada Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 22 Canada Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 23 Mexico Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 24 Mexico Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 25 Mexico Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 26 Mexico Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 27 Mexico Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 28 Europe Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 29 Europe Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 30 Europe Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 31 Europe Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 32 Europe Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33 Germany Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 34 Germany Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 35 Germany Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 36 Germany Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 37 UK Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 38 UK Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 39 UK Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 40 UK Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 France Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 42 France Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 43 France Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 44 France Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 45 Italy Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 46 Italy Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 47 Italy Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 48 Italy Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 49 Spain Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 50 Spain Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 51 Spain Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 52 Spain Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 53 Denmark Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 54 Denmark Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 55 Denmark Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 56 Denmark Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 57 Sweden Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 58 Sweden Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 59 Sweden Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 60 Sweden Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 61 Norway Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 62 Norway Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 63 Norway Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 64 Norway Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 65 Rest of Europe Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 66 Rest of Europe Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 67 Rest of Europe Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 68 Rest of Europe Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 74 Japan Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 75 Japan Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 76 Japan Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 77 Japan Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 78 China Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 79 China Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 80 China Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 81 China Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82 India Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 83 India Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 84 India Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 85 India Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 South Korea Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 87 South Korea Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 88 South Korea Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 89 South Korea Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 90 Australia Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 91 Australia Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 92 Australia Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 93 Australia Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 94 Thailand Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 95 Thailand Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 96 Thailand Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 97 Thailand Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 98 Rest of Asia Pacific Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 99 Rest of Asia Pacific Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 100 Rest of Asia Pacific Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 101 Rest of Asia Pacific Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 102 Latin America Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 103 Latin America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 104 Latin America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 105 Latin America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 106 Latin America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 107 Brazil Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 108 Brazil Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 109 Brazil Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 110 Brazil Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 111 Mexico Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 112 Mexico Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 113 Mexico Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 114 Mexico Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 115 Argentina Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 116 Argentina Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 117 Argentina Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 118 Argentina Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 119 Rest of Latin America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 120 Rest of Latin America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 121 Rest of Latin America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 122 Rest of Latin America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 123 Middle East & Africa Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 124 Middle East & Africa Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 125 Middle East & Africa Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 126 Middle East & Africa Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 127 Middle East & Africa Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 128 Saudi Arabia Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 129 Saudi Arabia Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 130 Saudi Arabia Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 131 Saudi Arabia Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 132 South Africa Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 133 South Africa Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 134 South Africa Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 135 South Africa Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 136 UAE Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 137 UAE Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 138 UAE Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 139 UAE Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 140 Kuwait Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 141 Kuwait Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 142 Kuwait Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 143 Kuwait Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 144 Rest of MEA Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 145 Rest of MEA Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 146 Rest of MEA Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 147 Rest of MEA Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 148 Key companies undergoing new product launches
  • Table 149 Key companies undergoing new acquisitions
  • Table 150 Key companies undergoing collaborations
  • Table 151 Key companies undergoing partnerships
  • Table 152 Key companies undergoing other strategies

List of Figures

  • Fig. 1 Endometriosis treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Treatment type and drug class segment snapshot
  • Fig. 10 Route of administration and distribution channel Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Women's health market value, 2024 (USD billion)
  • Fig. 13 Market trends & outlook
  • Fig. 14 Porter's five force analysis
  • Fig. 15 PESTEL analysis
  • Fig. 16 Endometriosis treatment market: Treatment type outlook and key takeaways
  • Fig. 17 Endometriosis treatment market: Treatment type movement analysis
  • Fig. 18 Pain medication market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Hormone therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Endometriosis treatment market: Drug class outlook and key takeaways
  • Fig. 21 Endometriosis treatment market: Drug class movement analysis
  • Fig. 22 NSAIDs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Oral contraceptives market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Gonadotropin-releasing hormone market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Endometriosis treatment market: Route of administration outlook and key takeaways
  • Fig. 27 Endometriosis treatment market: Route of administration movement analysis
  • Fig. 28 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Injectable market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Endometriosis treatment market: Distribution channel outlook and key takeaways
  • Fig. 32 Endometriosis treatment market: Distribution channel movement analysis
  • Fig. 33 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Endometriosis treatment market revenue, by region, 2024 & 2030 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 U.S. endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Prevalence of endometriosis in the U.S. (2021 - 2030) in Million
  • Fig. 42 Key country dynamics
  • Fig. 43 Canada endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Prevalence of endometriosis in the Canada. (2021 - 2030) in Million
  • Fig. 45 Key country dynamics
  • Fig. 46 Mexico endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Prevalence of endometriosis in the Mexico. (2021 - 2030) in Million
  • Fig. 48 Europe endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 UK endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Prevalence of endometriosis in the UK. (2021 - 2030) in Million
  • Fig. 52 Key country dynamics
  • Fig. 53 Germany endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Prevalence of endometriosis in the Germany. (2021 - 2030) in Million
  • Fig. 55 Key country dynamics
  • Fig. 56 France endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Prevalence of endometriosis in the France. (2021 - 2030) in Million
  • Fig. 58 Key country dynamics
  • Fig. 59 Italy endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Prevalence of endometriosis in the Italy. (2021 - 2030) in Million
  • Fig. 61 Key country dynamics
  • Fig. 62 Spain endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Prevalence of endometriosis in the Spain. (2021 - 2030) in Million
  • Fig. 64 Key country dynamics
  • Fig. 65 Denmark endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Prevalence of endometriosis in the Denmark. (2021 - 2030) in Million
  • Fig. 67 Key country dynamics
  • Fig. 68 Sweden endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Prevalence of endometriosis in the Sweden. (2021 - 2030) in Million
  • Fig. 70 Key country dynamics
  • Fig. 71 Norway endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Prevalence of endometriosis in the Norway. (2021 - 2030) in Million
  • Fig. 73 Rest of Europe endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Asia Pacific endometriosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Japan endometriosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Prevalence of endometriosis in the Japan. (2021 - 2030) in Million
  • Fig. 78 Key country dynamics
  • Fig. 79 China endometriosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Prevalence of endometriosis in the China. (2021 - 2030) in Million
  • Fig. 81 Key country dynamics
  • Fig. 82 India endometriosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Prevalence of endometriosis in the India. (2021 - 2030) in Million
  • Fig. 84 Key country dynamics
  • Fig. 85 Australia endometriosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Prevalence of endometriosis in the Australia. (2021 - 2030) in Million
  • Fig. 87 Key country dynamics
  • Fig. 88 Thailand endometriosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Prevalence of endometriosis in the Thailand. (2021 - 2030) in Million
  • Fig. 90 Key country dynamics
  • Fig. 91 South Korea endometriosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Prevalence of endometriosis in the South Korea. (2021 - 2030) in Million
  • Fig. 93 Rest of Asia Pacific endometriosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Latin America endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Brazil endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Prevalence of endometriosis in the Brazil. (2021 - 2030) in Million
  • Fig. 98 Key country dynamics
  • Fig. 99 Argentina endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Prevalence of endometriosis in the Argentina. (2021 - 2030) in Million
  • Fig. 101 Rest of Latin America endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 MEA endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 South Africa endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Prevalence of endometriosis in the South Africa. (2021 - 2030) in Million
  • Fig. 106 Key country dynamics
  • Fig. 107 Saudi Arabia endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 108 Prevalence of endometriosis in the Saudi Arabia. (2021 - 2030) in Million
  • Fig. 109 Key country dynamics
  • Fig. 110 UAE endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Prevalence of endometriosis in the UAE. (2021 - 2030) in Million
  • Fig. 112 Key country dynamics
  • Fig. 113 Kuwait endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 114 Prevalence of endometriosis in the Kuwait. (2021 - 2030) in Million
  • Fig. 115 Rest of MEA endometriosis treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 116 Company/competition categorization
  • Fig. 117 Company market position analysis, 2024
  • Fig. 118 Strategy mapping